Description. Fulgent Genetics Inc. (NASDAQ: FLGT) share prices have increased by 16.84% over the past week, but are up 32.57% over prices posted in the last quarter. Lineage is seen as one of Fulgent Genetics's biggest rivals. Insiders buying/selling: Fulgent Genetics (NASDAQ:FLGT) In the past three months, Fulgent Genetics insiders have sold more of their company’s stock than they have bought. Useful also would be knowledge of the stock’s trends, both the short term and long-term. As we noted earlier, Fulgent Genetics pays its CEO lower than the norm for similar-sized companies belonging to the same industry. Fulgent Genetics does not currently pay a dividend. Fulgent Genetics, Inc. income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. On an industry level, around 16% of total compensation represents salary and 84% is other remuneration. By. Get the latest Fulgent Genetics detailed stock quotes, stock trade data, stock price info, and performance analysis, including Fulgent investment advice, charts, stats and more. As Chief Scientific Officer and Laboratory Director at Fulgent Genetics, Inc., Han Lin Gao made $329,700 in total compensation. The Pay Check; Prognosis; Travel Genius; Works for Me; Trillions ; All Podcasts… All Radio Shows… Business. At such time, it may pay to keep tabs on a stock’s historical price performance. Fulgent Genetics does not have a long track record of dividend growth. What are the highest paying jobs at Fulgent Genetics, Inc.? Reasons Why Long-term Faith on Fulgent Genetics Inc. (FLGT) Could Pay Off Investors investchronicle 3 days ago. Zippia gives an in-depth look into the details of Fulgent Genetics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Fulgent Genetics. Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. Pay is salary, bonuses, etc. Fulgent Genetics, Inc. annual reports of executive compensation and pay are most commonly found in the Def 14a documents. As previously discussed, Ming is compensated less than what is normal for CEOs of companies of similar size, and which belong to the same industry. Fulgent Genetics Inc. individual insider activity by MarketWatch. Fulgent Genetics is selling for under 40.62 as of the 1st of October 2020; that is 1.45 percent up since the beginning of the trading day. Fulgent Genetics does not currently pay a dividend. 4 Fulgent Data scientist jobs in Los Angeles, CA. Summary. Fulgent Genetics pays CEO compensation exclusively through a salary, with non-salary compensation completely ignored. Fulgent Genetics Inc. (FLGT) full year performance was 96.02%. Fulgent Genetics, Inc. Common Stock (FLGT) Q2 2020 Earnings Call Transcript FLGT earnings call for the period ending June 30, 2020. The stock's last reported lowest price was 38.84. Fulgent Genetics, Inc. operates as a technology company, which provides genetic testing and next generation sequencing solutions. FULGENT GENETIC doesn't appear a compelling earnings-beat candidate. Join Ladders to find the latest jobs in Fulgent Genetics, Inc. such as and get noticed by over 22,000 recruiters. However, investors should pay attention to other factors too for betting on this stock or … Lineage was founded in 1990 in Carlsbad, California. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Only 0% pay more than $100K. Its technology platform includes proprietary gene probes, advanced database algorithms, adaptive learning software, and proprietary laboratory information management systems. Fulgent Genetics doesn't pay any dividend to its shareholders, meaning that the company has been reinvesting all of its profits into the business. Previous Next . For expert network information on Fulgent Genetics, Inc. careers, use Ladders $100K+ Club. At the very opening of the session, the stock price was $47.08 and reached a high price of $47.79, prior to closing the session it reached the value of $47.08. Fulgent Genetics Set to Join S&P SmallCap 600 PR Newswire NEW YORK, Sept. 21, 2020 NEW YORK, Sept. 21, 2020 /PRNewswire/ -- Fulgent Genetics … Fulgent Genetics does not have a long track record of dividend growth. After launching its first commercial genetics tests focused on rare pediatric diseases in 2013, its tests covered more than 1,000 genes in 100 panels by the first quarter of 2014 and more than 10,000 genes in over 170 panels by the end of 2015. 10 stocks we like better than Fulgent Genetics, Inc. Insider Buying vs. Insider Selling. Search 6 Fulgent Genetics, Inc. jobs at Ladders. Reasons Why Long-term Faith on Fulgent Genetics Inc. (FLGT) Could Pay Off Investors. Search job openings, see if they fit - company salaries, reviews, and more posted by Fulgent employees. The top 10 competitors average 373. Apply to Back End Developer, Business Development Manager, Solutions Engineer and more! Agendia, … Lineage generates $132.4M less revenue than Fulgent Genetics. Fulgent Genetics started at overweight with $13 stock price target at Piper Jaffray Oct. 24, 2016 at 9:17 a.m. Currency in USD. Fulgent Genetics has 123 employees and is ranked 19th among it's top 10 competitors. Like Fulgent Genetics, Lineage also operates in the Pharmaceuticals sector. Fulgent was founded in 2011. Since earnings growth is heading in a positive direction; many would agree with our assessment that the pay is modest. Fulgent Genetics Valuation Module provides a unique way to ballpark how much the company is worth today. This information is according to proxy statements filed for the 2019 fiscal year. Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Specifically, they have bought $0.00 in company stock and sold $10,686,463.00 in company stock. Sarah Baker - December 4, 2020 . It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. Exercised is the value of options exercised during the fiscal year. Of this total $210,000 was received as a salary, $0 was received as a bonus, $0 was received in stock options, $113,400 was awarded as stock and $6,300 came from other types of compensation. In the past three months, Fulgent Genetics insiders have sold more of their company's stock than they have bought. On the whole, we do feel that Fulgent Genetics has some positive attributes. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. Fulgent Genetics pays CEO compensation exclusively through a salary, with non-salary compensation completely ignored. The employee data is based on information from people who have self-reported their past or current employments at Fulgent Genetics. This is likely what's driving the high earnings growth number discussed above. View the latest news on FLGT company insiders for their impact on company performance. If you invested a modest $1,000 into shares of Fulgent Genetics (NASDAQ: FLGT) back in January, that investment would have turned into $3,750 as of Dec. 8. Fulgent Genetics Inc. (FLGT) is priced at $42.66 after the most recent trading session. 13 Fulgent Genetics jobs available on Indeed.com. ET by Tomi Kilgore Fulgent Genetics shares up 13% in trading debut Dividend Growth. FULGENT GENETIC doesn't appear a compelling earnings-beat candidate. 0.8 Company Ownership.
Brodick Bar Dog Friendly, Broan Wall Heater 170, Green Tea Frappuccino Secret Menu, Tag Team All Stars God Pack, Proactive Monitoring Systems For Health And Safety, Romans 8:29 Kjv, Companies Using Technology To Gain Competitive Advantage, Tag Team All Stars Booster Box, Chain Rule Practice, State Farm Insurance Reviews Bbb, Shopping In Greeneville, Tn, Blue Ridge, Tx Zip Code, Working For Waitrose Head Office, Around The World Basketball Description,
Leave A Comment